|
1
|
Smith IM, Stephan C, Hogardt M, Klawe C,
Tintelnot K and Rickerts V: Cryptococcosis due to Cryptococcus
gattii in Germany from 2004–2013. Int J Med Microbiol.
305:719–723. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teodoro VL, Gullo FP, Sardi Jde C, Torres
EM, Fusco-Almeida AM and Mendes-Giannini MJ: Environmental
isolation, biochemical identification, and antifungal drug
susceptibility of Cryptococcus species. Rev Soc Bras Med
Trop. 46:759–764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fang W, Fa Z and Liao W: Epidemiology of
Cryptococcus and cryptococcosis in China. Fungal Genet Biol.
78:7–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamakawa H, Yoshida M, Yabe M, Baba E,
Okuda K, Fujimoto S, Katagi H, Ishikawa T, Takagi M and Kuwano K:
Correlation between clinical characteristics and chest computed
tomography findings of pulmonary cryptococcosis. Pulm Med.
2015:7034072015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alanio A, Desnos-Ollivier M and Dromer F:
Dynamics of Cryptococcus neoformans-macrophage interactions
reveal that fungal background influences outcome during
cryptococcal meningoencephalitis in humans. MBio. 2(4): e00158–11.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schelenz S, Barnes RA, Barton RC,
Cleverley JR, Lucas SB, Kibbler CC and Denning DW: British Society
for Medical Mycology: British Society for Medical Mycology best
practice recommendations for the diagnosis of serious fungal
diseases. Lancet Infect Dis. 15:461–474. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perfect JR, Dismukes WE, Dromer F, Goldman
DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O,
Nguyen MH, et al: Clinical practice guidelines for the management
of cryptococcal disease: 2010 update by the infectious diseases
society of america. Clin Infect Dis. 50:291–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sider L and Westcott MA: Pulmonary
manifestations of cryptococcosis in patients with AIDS: CT
features. J Thorac Imaging. 9:78–84. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brizendine KD, Baddley JW and Pappas PG:
Predictors of mortality and differences in clinical features among
patients with cryptococcosis according to immune status. PLoS One.
8:e604312013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kishi K, Homma S, Kurosaki A, Kohno T,
Motoi N and Yoshimura K: Clinical features and high-resolution CT
findings of pulmonary cryptococcosis in non-AIDS patients. Respir
Med. 100:807–812. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fox DL and Müller NL: Pulmonary
cryptococcosis in immunocompetent patients: CT findings in 12
patients. AJR Am J Roentgenol. 185:622–626. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Espinel-Ingroff A and Kidd SE: Current
trends in the prevalence of Cryptococcus gattii in the
United States and Canada. Infect Drug Resist. 8:89–97. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guarner J and Brandt ME: Histopathologic
diagnosis of fungal infections in the 21st century. Clin Microbiol
Rev. 24:247–280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barton RC: Laboratory diagnosis of
invasive aspergillosis: From diagnosis to prediction of outcome.
Scientifica (Cairo). 2013:4594052013.PubMed/NCBI
|
|
15
|
Ye XD, Ye JD, Yuan Z, Li WT and Xiao XS:
Dynamic CT of solitary pulmonary nodules: Comparison of contrast
medium distribution characteristic of malignant and benign lesions.
Clin Transl Oncol. 16:49–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng X, Yao Z, Ling B, et al: Analysis of
the varieties, genotypes and mating types of 110 clinical
cryptococcal isolates from China. Chin J Microbiol Immunol.
28:193–197. 2008.
|
|
17
|
Wu SY, Lei Y, Kang M, Xiao YL and Chen ZX:
Molecular characterisation of clinical Cryptococcus neoformans
Cryptococcus gattii isolates from Sichuan province, China.
Mycoses. 58:280–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Galanis E, Macdougall L, Kidd S and
Morshed M: British Columbia Cryptococcus gattii Working
Group: Epidemiology of Cryptococcus gattii, British
Columbia, Canada, 1999–2007. Emerg Infect Dis. 16:251–257. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie X, Xu B, Yu C, Chen M, Yao D, Xu X,
Cai X, Ding C, Wang L and Huang X: Clinical analysis of pulmonary
cryptococcosis in non-HIV patients in south China. Int J Clin Exp
Med. 8:3114–3119. 2015.PubMed/NCBI
|
|
20
|
Xie LX, Chen YS, Liu SY and Shi YX:
Pulmonary cryptococcosis: Comparison of CT findings in
immunocompetent and immunocompromised patients. Acta Radiol.
56:447–453. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuchong C, Fubin C, Jianghan C, Fenglian
W, Nan X, Minghui Y, Yalin S and Zhizhong Z: Cryptococcosis in
China (1985–2010): Review of cases from Chinese database.
Mycopathologia. 173:329–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen YY and Lai CH: Nationwide
population-based epidemiologic study of cryptococcal meningitis in
Taiwan. Neuroepidemiology. 36:79–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Li N, Zhang Y, Li H, Chen X, Wang
S, Zhang X, Zhang R, Xu J, Shi J and Yung RC: Clinical analysis of
76 patients pathologically diagnosed with pulmonary cryptococcosis.
Eur Respir J. 40:1191–1200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Charlier C, Nielsen K, Daou S, Brigitte M,
Chretien F and Dromer F: Evidence of a role for monocytes in
dissemination and brain invasion by Cryptococcus neoformans.
Infect Immun. 77:120–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sorrell TC, Juillard PG, Djordjevic JT,
Kaufman-Francis K, Dietmann A, Milonig A, Combes V and Grau GE:
Cryptococcal transmigration across a model brain blood-barrier:
Evidence of the Trojan horse mechanism and differences between
Cryptococcus neoformans var. Grubii strain H99 and
Cryptococcus gattii strain R265. Microbes Infect. 18:57–67.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee WY, Wu JT, Jeng CM, HSU CY, Liu JS,
Wang YC, Wu CY, Chang HY, Huang JC, Yang CM and Kung CH: CT
Findings of pulmonary cryptococcosis: A series of 12 cases. Chin J
Radiol. 30:319–325. 2005.
|
|
27
|
Ye F, Xie JX, Zeng QS, Chen GQ, Zhong SQ
and Zhong NS: Retrospective analysis of 76 immunocompetent patients
with primary pulmonary cryptococcosis. Lung. 190:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lindell RM, Hartman TE, Nadrous HF and Ryu
JH: Pulmonary cryptococcosis: CT findings in immunocompetent
patients. Radiology. 236:326–331. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zinck SE, Leung AN, Frost M, Berry GJ and
Müller NL: Pulmonary Cryptococcosis: CT and Pathologic Findings. J
Comput Assist Tomogr. 26:330–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YR, Choi YW, Lee KJ, Jeon SC, Park CK
and Heo JN: CT halo sign: The spectrum of pulmonary diseases. Br J
Radiol. 78:862–865. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang WC, Tzao C, Hsu HH, Lee SC, Huang
KL, Tung HJ and Chen CY: Pulmonary cryptococcosis: Comparison of
clinical and radiographic characteristics in immunocompetent
andimmunocompromised patients. Chest. 129:333–340. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saag MS, Graybill RJ, Larsen RA, Pappas
PG, Perfect JR, Powderly WG, Sobel JD and Dismukes WE: Practice
guidelines for the management of cryptococcal disease. Infectious
Diseases Society of America. Clin Infect Dis. 30:710–718. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Perfect JR, Dismukes WE, Dromer F, Goldman
DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O,
Nguyen MH, et al: Clinical practice guidelines for the management
of cryptococcal disease: 2010 update by the infectious diseases
society of America. Clin Infect Dis. 50:291–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
